Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market
Holding DMAC?
Track your performance easily

Diamedica Therapeutics (DMAC) Stock Investors

477 Followers
Based on 765,504 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DMAC
On average, investors allocate 0.00% of their portfolios to DMAC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 765,504 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DMAC

1.7%
Last 7
Days
2.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DMAC, out of 765,504 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DMAC Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,640 investors who made their portfolios public
The table shows changes in DMAC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DMAC Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.34%
+0.89%
-0.84%
31.36B
Consumer Cyclical
Viking Therapeutics
4.92%
+3.64%
+5.49%
7.04B
Healthcare
Plug Power
5.29%
+0.15%
+0.20%
2.21B
Industrials
XPeng, Inc. ADR
5.57%
-1.15%
-1.49%
11.61B
Consumer Cyclical
Li Auto
5.63%
-1.52%
-3.83%
25.33B
Consumer Cyclical
Lucid Group
5.84%
+0.23%
+0.82%
5.86B
Consumer Cyclical
Nio
9.82%
-0.44%
-0.19%
10.82B
Consumer Cyclical
Enphase Energy
4.82%
-0.18%
+3.36%
11.82B
Technology
Bristol-Myers Squibb
3.55%
-0.10%
-2.40%
112.46B
Healthcare
Block
4.28%
-0.06%
+1.28%
44.75B
Technology
Based on the activity of 765,504 active portfolios
Open your Smart Portfolio

DMAC Investor Analysis

DMAC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.5%
of DMAC holders
are under 35
Average Segment Performance
Average P/E Ratio23.45
Beta10.33
Dividend Yield51.46%
DMAC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
37.5%
of DMAC holders
are between 35–55
Average Segment Performance
Average P/E Ratio21.88
Beta20.26
Dividend Yield24.92%
DMAC investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of DMAC holders
are over 55
Average Segment Performance
Average P/E Ratio21.22
Beta8.93
Dividend Yield41.53%
Overview of age group and performance of DMAC stock investors
See who invests in DMAC according to age group and performance.

FAQ

How many retail Investors hold DMAC?
<0.1% of TipRanks' retail investors hold DMAC in their portfolios.
    What is DMAC Investor Sentiment?
    DMAC’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DMAC in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of DMAC in the last 7 days.
        What percentage of retail investors changed their holding of DMAC in the last 30 days?
        ▼ 2.4% of TipRanks' retail investors changed their holding of DMAC in the last 30 days.
          What is the average age of retail investors who hold DMAC?
          The average age of DMAC Holders is over 55.
            What other stocks have DMAC investors also bought?
            DMAC Investors also bought DKNG, VKTX, PLUG, XPEV, LI, LCID, NIO, ENPH, BMY, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AGENAgenus
              AAgilent
              BDXBecton Dickinson
              BIIBBiogen
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis